3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Neoplasms
3
Stomatitis
2
Recurrence
2
Nasopharyngeal Carcinoma
2
Meningeal Carcinomatosis
2
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Anemia
2
Vitamin B 12 Deficiency
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Thrombocytopenia
1
Stroke
1
Stomach Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Peripheral Nervous System Diseases
1
Papillomavirus Infections
1
Ovarian Neoplasms
1
Oligodendroglioma
1
Neutropenia
1
Neuralgia
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Myocardial Infarction
1
Mesothelioma
1
Head and Neck Neoplasms
1
HR-positive Breast Cancer
1
Gliosarcoma
1
Interventions
Acupuncture Therapy
10
Exercise
6
Cryotherapy
6
Paclitaxel
5
Glutamine
4
Surveys and Questionnaires
3
Duloxetine Hydrochloride
3
Dexamethasone
3
Bortezomib
3
Acetylcysteine
3
Thioctic Acid
2
Tablets
2
Sodium Chloride
2
Saline Solution
2
Physical Therapy Modalities
2
Low-Level Light Therapy
2
Fish Oils
2
Fatty Acids, Omega-3
2
ziconotide
1
pembrolizumab
1
nicotinamide-beta-riboside
1
glutamic acid diethyl ester
1
enfortumab vedotin
1
Yoga
1
XELOX
1
Vitamin D
1
Vitamin B Complex
1
Vitamin B 6
1
Vitamin B 12
1
Ultrasonic Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Peripheral Nervous System Diseases
×
Vitamin B 12
×
Clear all
NCT02795572
2019-07-05
CIPN
AHS Cancer Control Alberta
Phase 2
Terminated
13 enrolled